| Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. | |
| | |
MedLine Citation:
|
PMID: 8062368 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Subacute thrombosis of coronary stents may occur up to the end of the first month after their implantation and remains the major problem associated with the technique. A cohort of 238 patients with placement of one or more stents in 244 arteries was monitored for this period. All patients were given 500 mg/day of ticlopidine (started 3 days before) and a push dose of 10,000 IU of heparin during the procedure, then 1,000-1,500 IU/hr for 20 hr. Following removal of the arterial introducer, they were kept on subcutaneous heparin for 1 week and ticlopidine (500 mg/day) for 3-6 months. Nine patients (3.8%) showed evidence of thrombosis at 7 days. The overall thrombosis rate at 30 days was 4.2% (3.5% for elective stents, as compared with 7.9% associated with occlusive dissections). Emergency treatment by further angioplasty (8 cases) and intracoronary thrombolysis (5 cases) was undertaken. Complications were as follows: 5 deaths (2%), 3 MI (1.2%), 2 non-Q MI (1.7%). Three predictive factors for subacute thrombosis were identified: age < 70 (p = 0.00006), unstable angina (p = 0.006) and arterial diameter less than 3 mm (p = 0.043). The peripheral vascular complication rate was 4.6%. This study suggests that preventive treatment with ticlopidine appears to reduce the incidence of subacute thrombosis of stents in patients > 70 years of age. Furthermore, the combination of ticlopidine and heparin facilitates laboratory monitoring after stenting. Stenting is thought to represent definitive treatment in situations where placement for occlusive dissection is the indication. |
| | |
Authors:
|
P Barragan; J Sainsous; M Silvestri; J L Bouvier; B Comet; J B Siméoni; C Charmasson; M Bremondy |
Related Documents
:
|
19057028 - Intravascular ultrasound analysis of small-vessel lesions treated with novel ultra-low ... 17670228 - Incorporated airway stent: a useful option for treating tracheal stenosis after metalli... 19630108 - Clinical outcomes of self-expandable metal stents in palliation of malignant anastomoti... 10415248 - Self-expanding metallic stents in the management of pyloric dysfunction after gastric p... 23076828 - Combination of cyclosporine a with corticosteroids is effective for the treatment of ne... 23442748 - A controlled, parallel, cluster-randomized trial of community-wide screening and treatm... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Catheterization and cardiovascular diagnosis Volume: 32 ISSN: 0098-6569 ISO Abbreviation: Cathet Cardiovasc Diagn Publication Date: 1994 Jun |
Date Detail:
|
Created Date: 1994-09-22 Completed Date: 1994-09-22 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7508512 Medline TA: Cathet Cardiovasc Diagn Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 133-8 Citation Subset: IM |
Affiliation:
|
Centre Cardio-vasculaire les Alpilles/Les Alpilles Cardiovascular Center, Marseilles, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Angioplasty, Transluminal, Percutaneous Coronary* Coronary Thrombosis / prevention & control*, therapy Female Heparin / therapeutic use* Humans Male Middle Aged Prospective Studies Stents* / adverse effects Ticlopidine / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
55142-85-3/Ticlopidine; 9005-49-6/Heparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Balloon angioplasty for treatment of in-stent restenosis: feasibility, safety, and efficacy.
Next Document: Endoluminal stenting of narrowed saphenous vein grafts: long-term clinical and angiographic follow-u...